DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Credit Suisse Maintains Outperform on Acceleron Pharma, Raises Price Target to $99

Credit Suisse maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $58 to $99.

Benzinga · 01/28/2020 13:08

Credit Suisse maintains Acceleron Pharma (NASDAQ:XLRN) with a Outperform and raises the price target from $58 to $99.